Insulin Glargine-aglr Injection shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting Sep 1, 2026 · last update Sep 1, 2026
Manufacturers: Eli Lilly and Co.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Rezvoglar, Injection, 100 [iU]/1 mL (NDC 0002-8980-05) | Eli Lilly and Co. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday through Friday from 9am to 8pm for assistance. | Posted Sep 1, 2026 Updated Sep 1, 2026 Discontinued Sep 1, 2026 |